Verrica Pharmaceuticals Inc. (VRCA) stock
Close on Nov 13, 2026Market cap $61.16MP/E –Yield –
Verrica Pharmaceuticals statistics
65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 10, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 2.04
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 121.7%
- 10.8%
- Shares Change (QoQ)
- 0.00%
- 0.50%
- Shares Held by Institutions
- 27.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 244,405
- –
- Short Interest Change
- 26.9%
- -0.80%
- Short % of Shares Outstanding
- 1.42%
- 6.30%
- Days to Cover
- 4.58
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $9.82
- –
- 52-Week Low
- $3.08
- –
- 20-Day Moving Average
- $3.48
- –
- 50-Day Moving Average
- $4.06
- –
- 200-Day Moving Average
- $5.41
- –
- Average True Range (14)
- $0.35
- –
- Price Change (1 Week)
- 11.6%
- -1.15%
- Price Change (1 Month)
- -5.82%
- -4.87%
- Price Change (3 Months)
- -27.2%
- -21.0%
- Price Change (6 Months)
- -43.2%
- -20.6%
- Price Change (YTD)
- -57.2%
- -23.6%
- Price Change (1 Year)
- -6.81%
- -22.4%
- Price Change (3 Years)
- -87.8%
- -29.5%
- Price Change (5 Years)
- -97.1%
- -77.9%
- Average Volume (10 Days)
- 68,057
- –
- Average Volume (20 Days)
- 58,237
- –
- Average Volume (90 Days)
- 62,129
- –
- Relative Volume
- 0.30
- 0.70
- Relative Strength Index (14)
- 47.3
- 43.4
- Volatility (1 Year)
- 95.5%
- 80.1%
- Beta (5 Years)
- 1.08
- 1.07
MarginsIndustry
- EBITDA Margin
- -184.2%
- -27.7%
Returns on capitalIndustry
- Return on Assets (ROA)
- -107.3%
- -40.6%
- Return on Capital Employed (ROCE)
- -235.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.66
- 3.30
- Quick Ratio
- 1.17
- 2.39
- Interest Coverage
- -21.93
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- -25.7%
- 6.82%
- Revenue Growth (3Y CAGR)
- 57.9%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.57
- 0.40
- Revenue Per Employee
- $301.20K
- $429.29K
- Profits Per Employee
- -$569.95K
- -$689.41K
- Employee Count
- 76
- 74
- WACC
- 10.5%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $14.39M
- $17.76M
- Net Cash Per Share
- $0.84
- $0.80
- Equity (Book Value)
- -$5.97M
- $53.89M
- Book Value Per Share
- -$0.35
- $1.50
- Tangible Book Value
- -$5.97M
- $27.13M
- Working Capital
- $14.47M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -70.8%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $1.92M
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- -14.33
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | VRCA | S&P 500 | Difference | VRCA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.6% | -3.0% | +2.5 pts | ||
| 3 months | -26.7% | -2.8% | −24.0 pts | ||
| Year to date | -57.2% | +11.5% | −68.6 pts | ||
| 1 year | -8.0% | +13.5% | −21.5 pts | ||
| 3 years | -88.2% | +77.7% | −165.9 pts | -50.9% | +21.1% |
| 5 years | -97.1% | +72.6% | −169.7 pts | -50.8% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M VRCA shares were sold short on Oct 30, 2026, up 26.9% from the previous report. At recent volumes it would take 4.6 days to buy them back. Over the last 20 sessions, 43.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 244,405 | +26.9% | 53,391 | 4.6 |
| Oct 15, 2026 | 192,613 | -1.8% | 50,109 | 3.8 |
| Sep 30, 2026 | 196,221 | -3.2% | 48,284 | 4.1 |
| Sep 15, 2026 | 202,755 | -8.9% | 48,525 | 4.2 |
| Aug 31, 2026 | 222,572 | -17.4% | 156,721 | 1.4 |
| Aug 14, 2026 | 269,349 | -6.4% | 52,177 | 5.2 |
| Jul 31, 2026 | 287,747 | -8.9% | 29,236 | 9.8 |
| Jul 15, 2026 | 315,760 | -2.7% | 28,529 | 11.1 |
| Jun 30, 2026 | 324,679 | -7.7% | 51,545 | 6.3 |
| Jun 15, 2026 | 351,818 | -7.2% | 37,985 | 9.3 |
| May 29, 2026 | 379,278 | -8.0% | 40,570 | 9.3 |
| May 15, 2026 | 412,480 | -29.2% | 115,949 | 3.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?